Novonesis A/S (LON:0Q4U)
408.85
-0.53 (-0.13%)
At close: Apr 16, 2025
Novonesis Revenue
In the year 2024, Novonesis had annual revenue of 3.83B EUR with 59.58% growth. Novonesis had revenue of 1.00B in the quarter ending December 31, 2024, a decrease of -78.26%.
Revenue
3.83B EUR
Revenue Growth
+59.58%
P/S Ratio
6.93
Revenue / Employee
362.27K EUR
Employees
10,582
Market Cap
21.97B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.83B | 1.43B | 59.58% |
Dec 31, 2023 | 2.40B | -15.15B | -86.31% |
Dec 31, 2022 | 17.55B | 2.60B | 17.40% |
Dec 31, 2021 | 14.95B | 939.00M | 6.70% |
Dec 31, 2020 | 14.01B | -362.00M | -2.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |